Spreadsheet Data
Audit the saved peer set and the method inputs behind the blended fair value.
Review the saved peer set across price, scale, operating metrics, and raw valuation multiples.
| Peer | Price | Market Cap | Enterprise Value | Revenue | EBITDA |
|---|
| Net Income |
|---|
| P/E |
|---|
| P/S |
|---|
| EV/EBITDA |
|---|
ZB ZBH ZIMMER BIOMET HOLDINGS, INC. FY ended Feb 10, 2026 | $100.91 | $19.25B | $23.27B | $8.23B | $1.92B | $705.10M | 28.43x | 2.34x | 12.09x |
SY SYK STRYKER CORP FY ended Jan 31, 2026 | $330.69 | $126.84B | $140.75B | $25.12B | $6.29B | $3.25B | 39.37x | 5.05x | 22.38x |
BD BDX BECTON DICKINSON & CO FY ended Oct 31, 2025 | $189.52 | $51.62B | $72.77B | $21.84B | $4.81B | $1.68B | 32.56x | 2.36x | 13.27x |
IA IART INTEGRA LIFESCIENCES HOLDINGS CORP FY ended Feb 25, 2026 | $16.89 | $1.31B | $3.13B | $1.64B | -$452.37M | -$516.47M | -2.51x | 0.80x | — |
See which peer averages feed the weighted fair value and which methods are excluded.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVActive | Enterprise Multiple | 14.76x | 3/4 | $15.22M | $1.14 | Included in the active peer mix. |
Price / Sales PSActive | Equity Multiple | 2.64x | 4/4 | $297.72M | $22.25 | Included in the active peer mix. |
Price / Earnings PEExcluded | Equity Multiple | 24.46x | 4/4 | -$266.15M | — | Target fundamentals do not produce a usable positive equity value. |
Open the saved peer table used to audit the fair value view.
| Peer | Price | Market Cap | Enterprise Value | Revenue | EBITDA | Net Income | P/E | P/S | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
ZB ZBH ZIMMER BIOMET HOLDINGS, INC. FY ended Feb 10, 2026 | $100.91 | $19.25B | $23.27B | $8.23B | $1.92B | $705.10M | 28.43x | 2.34x | 12.09x |
SY SYK STRYKER CORP FY ended Jan 31, 2026 | $330.69 | $126.84B | $140.75B | $25.12B | $6.29B | $3.25B | 39.37x | 5.05x | 22.38x |
BD BDX BECTON DICKINSON & CO FY ended Oct 31, 2025 | $189.52 | $51.62B | $72.77B | $21.84B | $4.81B | $1.68B | 32.56x | 2.36x | 13.27x |
IA IART INTEGRA LIFESCIENCES HOLDINGS CORP FY ended Feb 25, 2026 | $16.89 | $1.31B | $3.13B | $1.64B | -$452.37M | -$516.47M | -2.51x | 0.80x | — |
Open the peer-average inputs behind the weighted result.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVActive | Enterprise Multiple | 14.76x | 3/4 | $15.22M | $1.14 | Included in the active peer mix. |
Price / Sales PSActive | Equity Multiple | 2.64x | 4/4 | $297.72M | $22.25 | Included in the active peer mix. |
Price / Earnings PEExcluded | Equity Multiple | 24.46x | 4/4 | -$266.15M | — | Target fundamentals do not produce a usable positive equity value. |
